XENE — Xenon Pharmaceuticals Inc. stock price, charts and financials

QT41Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
39.75
-17.60-30.69%
OverviewShort InterestFilings
XENEQT41Xenon Pharmaceuticals Inc.·NASDAQ
39.75-30.69%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 2026S-8 POSS-8 POS
Jun 03, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
#1 / 25 of 263
Page
▼
/ 11